Trial Profile
Clinical Trials Insight: 700057635
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 14 Jul 2010
Price :
$35
*
At a glance
- Drugs GAI 122 (Primary)
- Indications Neurological disorders
- Focus Adverse reactions
- 21 Jan 2010 New trial record